Clinical trial
A Single-Arm, Open-Label, Single-Center Clinical Study on Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT07539662 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Arm, Open-Label, Single-Center Clinical Study on Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- December 29, 2025
- Completion date
- December 31, 2027
- Enrollment
- 8 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
als (amyotrophic lateral sclerosis)